Glenmede Trust CO Na Biolife Solutions Inc Transaction History

Glenmede Trust CO Na

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 16, 2022	SELL	$14.64 - $26.7 $181,945 - $331,827	-12,428 Reduced 47.56%	13,703 $311,000
Q2 2022 Aug 15, 2022	BUY	$10.54 - $24.2 $2,603 - $5,977	247 Added 0.95%	26,131 $360,000
Q1 2022 May 16, 2022	BUY	$20.81 - $37.29 $10,009 - $17,936	481 Added 1.89%	25,884 $588,000
Q4 2021 Feb 15, 2022	BUY	$32.99 - $58.55 $29,295 - $51,992	888 Added 3.62%	25,403 $946,000
Q3 2021 Nov 15, 2021	BUY	$42.03 - $60.5 $1.03 Million - $1.48 Million	24,515 New	24,515 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$27.5 - $45.75 $1,045 - $1,738	-38 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$16.04 - $28.94 $609 - $1,099	38 New	38 $1,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.16B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.